News

Composite polymer particles adorned with gold nanoparticles could improve the accuracy of infectious disease testing, reports a new study.

Scientists have developed a novel blood test to measure the immune response to the Epstein-Barr virus, the leading risk factor for developing multiple sclerosis. The test has the potential to be applied in clinical trials that target the virus.

A new radiotheranostic system has the ability to detect and treat ovarian cancer noninvasively, providing more personalized treatment to patients.

Disturbed gut flora during the first years of life is associated with diagnoses such as autism and ADHD later in life. This is according to a study led by researchers at the University of Florida and Linköping University.

Researchers have devised a more accurate method for detecting the emerging Powassan virus in ticks. This robust, real-time approach reduces the incidence of false negative test results.

Researchers have used data from UK Biobank participants to reveal that diabetes, traffic-related air pollution and alcohol intake are the most harmful out of 15 modifiable risk factors for dementia.

While most CKD cases originate from lifestyle-related factors or diseases such as diabetes and hypertension, the underlying causes of CKD remain unknown for about one in every ten people with end-stage renal failure.

Stressful experiences in midlife or during childhood may be associated with a higher risk of developing Alzheimer's disease and neuroinflammation, respectively.

A new whole-blood test for assessing traumatic brain injury in army troops has received US Food and Drug Administration clearance.

The Tasmanian devil population has been afflicted with an infectious cancer that has pushed the species to near extinction. The genomic interactions between the disease and its host correlate with how quickly an animal becomes infected after exposure.